The DOI matches its Crossref record; 48 of the 53 references it cites were found in a registry or an index.
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
Open accessAbstract
The WHO just released in May 2022 a report on the state of the obesity pandemic in Europe, stating that 60% of citizens in the area of Europe are either overweight or obese, and highlighting the implications of the obesity pandemic, especially as it interacts with the COVID pandemic to create a twin pandemic, to increase morbidity and mortality. Obesity is a complex disease which has reached pandemic dimensions. The worldwide prevalence of obesity has nearly tripled since 1975, mainly due to the adoption of a progressively more sedentary lifestyle and the consumption of less healthy diets. We first report herein updated prevalence rates of overweight and obesity by sex, age, and region first in Europe, per the WHO report, and then worldwide between 1980 and 2019, as we analyze and present herein the data provided by the Global Burden of Disease Study. The prevalence of obesity is higher in women than in men of any age and the prevalence of both overweight and obesity increases with age and has reached their highest point between the ages of 50 to 65 years showing a slight downward trend afterwards. The age-standardized prevalence of obesity has increased from 4.6% in 1980 to 14.0% in 2019. The American and European region have the highest obesity prevalence and the USA and Russia are the countries with the most obese residents. Given dire implications in terms of comorbidities and mortality, these updated epidemiological findings call for coordinated actions from local and regional governments, the scientific community and individual patients alike, as well as the food industry for the obesity pandemic to be controlled and alleviated. We can hopefully learn from the COVID-19 pandemic, where collaborative efforts worldwide, focused intense work at both the local and global level and well-coordinated leadership have demonstrated that humankind is capable of amazing accomplishments by leveraging science and public health, and that we can finally make strides in terms of understanding and combating the obesity pandemic and its dire comorbidities including diabetes, NAFLD, CVD and obesity associated malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity rates are rising globally, with the age-standardized prevalence increasing from 4.6% in 1980 to 14.0% in 2019 [1].”
From Beyond Calories: Individual Metabolic and Hormonal Adaptations Driving Variability in Weight Management—A State-of-the-Art Narrative Review (2024) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717 · cited 1×
“more central body fat distribution, these populations have [33].”
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126 · cited 1×
“In addition, regional differences are largely associated with differences in socioeconomic status [30].”
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Chooi, Y. C., Ding, C., & Magkos, F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.09.005 · Cited by 2,997 · cited 1×
“Obesity in the European region stating that both overweight and obesity rates have reached epidemic proportions across the European Region, where 59% of adults and almost 1 in 3 children are suffering from overweight or obesity [20], we publish this report as an update on the epidemiology of obesity [21].”
The Spirit Level: Why More Equal Societies Almost always do Better
Johnston, R. J. (2009) · Political Geography · doi:10.1016/j.polgeo.2009.10.003 · Cited by 2,054
The Emerging Risk Factors Collaboration (2011) · The Lancet · doi:10.1016/s0140-6736(11)60105-0 · Cited by 1,216 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Palaiodimos, L., Kokkinidis, D. G., Li, W., Karamanis, D., Ognibene, J., Arora, S., Southern, W. N., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154262 · Cited by 864
Self-citationAnstey, K. J., Cherbuin, N., Budge, M., & Young, J. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00825.x · Cited by 855 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065174 · Cited by 772 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Obesity and its implications for covid-19 mortality
Dietz, W., & Santos‐Burgoa, C. (2020) · Obesity · doi:10.1002/oby.22818 · Cited by 687
Seidell, J. C., Përusse, L., Després, J., & Bouchard, C. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.3.315 · Cited by 523 · cited 1×
“taneous and visceral fat, whereas variation in hip circumference represents variation in bone structure (pelvic width), gluteal muscle, and subcutaneous gluteal fat [34].”
Obesity in patients with COVID-19: a systematic review and meta-analysis
Huang, Y., Lu, Y., Huang, Y.-M., Wang, M., Ling, W., Sui, Y., & Zhao, H.-L. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154378 · Cited by 454
Upadhyay, J., Farr, O. M., Perakakis, N., Ghaly, W., & Mantzoros, C. S. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.004 · Cited by 425 · cited 1×
“common causes for the obesity epidemic that is taking over many parts of the world during the last decades [15,16].”
Self-citationBody mass index and susceptibility to knee osteoarthritis: A systematic review and meta-analysis
Jiang, L., Tian, W., Wang, Y., Rong, J., Bao, C., Liu, Y., Zhao, Y., & Wang, C. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.05.015 · Cited by 382 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Moderate and Severe Obesity Have Large Differences in Health Care Costs
Andreyeva, T., Sturm, R., & Ringel, J. S. (2004) · Obesity Research · doi:10.1038/oby.2004.243 · Cited by 318 · cited 1×
“Interestingly, it has been demonstrated that BMI 30–40 kg/m2 is associated with almost 50%, and BMI over 40 kg/m2 is associated with 100% greater healthcare expenditures due to treatment of obesity comorbidities [11].”
Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups
Lear, S. A., James, P., Ko, G. T., & Kumanyika, S. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.70 · Cited by 289 · cited 1×
“apparently reflect the lack of a standardized approach [35].”
Jiang, L., Rong, J., Wang, Y., Hu, F., Bao, C., Li, X., & Zhao, Y. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.04.011 · Cited by 274 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy
Yeo, G. S. H., Chao, D. H. M., Siegert, A., Koerperich, Z. M., Ericson, M. D., Simonds, S. E., Larson, C. M., Luquet, S. H., Clarke, I. J., Sharma, S. D., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101206 · Cited by 254 · cited 1×
“Except that, at the end of 2020, the US FDA approved setmelanotide, a melanocortin 4 receptor agonist for use in individuals with severe obesity due to the rare genetic leptin receptor deficiency [53].”
Pharmacotherapy of obesity: available medications and drugs under investigation.
Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A.-E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.010 · Cited by 248 · cited 1×
“Phentermine, the most widely prescribed weight loss drug in the USA, is only approved for the short-term treatment of obesity [57].”
Self-citationColchero, M. A., Molina, M., & Guerrero-López, C. M. (2017) · Journal of Nutrition · doi:10.3945/jn.117.251892 · Cited by 237
Garawi, F., Devries, K. M., Thorogood, N., & Uauy, R. D. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.86 · Cited by 233
Obesity as a risk factor for Alzheimer's disease: weighing the evidence
Alford, S., Patel, D. K., Perakakis, N., & Mantzoros, C. S. (2017) · Obesity Reviews · doi:10.1111/obr.12629 · Cited by 232 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Self-citationCommentary: Obesity: The “Achilles heel” for COVID-19?
Muscogiuri, G., Pugliese, G., Barrea, L., Savastano, S., & Colao, A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154251 · Cited by 230 · cited 1×
“Furthermore, obesity impedes diaphragmatic excursion in supine patients by compromising ventilation [44].”
Wells, J. C. K., Marphatia, A. A., Cole, T. J., & McCoy, D. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.03.029 · Cited by 186 · cited 1×
“The fact that females constantly lead in terms of the proportions of obesity is expected, given the biologically driven higher percentage of body fat in women [25,26].”
Kadouh, H., Chedid, V., Halawi, H., Burton, D. D., Clark, M. M., Khemani, D., Vella, A., Acosta, A., & Camilleri, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz140 · Cited by 166 · cited 1×
“regional fat stores while lean body mass is preserved resulting in a favorable effect on metabolic and cardiovascular risks of obesity [55].”
Evaluating the 2014 sugar-sweetened beverage tax in Chile: An observational study in urban areas
Nakamura, R., Mirelman, A. J., Cuadrado, C., Silva-Illanes, N., Dunstan, J., & Suhrcke, M. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002596 · Cited by 153
Prevalence and Secular Trends in Obesity Among Chinese Adults, 1991−2011
Mi, Y.-J., Zhang, B., Wang, H., Yan, J., Han, W., Zhao, J., Liu, D., & Tian, Q. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.05.005 · Cited by 148
Visceral fat is associated to the severity of COVID-19
Favrè, G., Legueult, K., Pradier, C., Raffaelli, C., Ichaï, C., Iannelli, A., Redheuil, A. B., Lucidarme, O., & Esnault, V. L. M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154440 · Cited by 146
Obesity, income and gender: The changing global relationship
Ameye, H., & Swinnen, J. (2019) · Global Food Security · doi:10.1016/j.gfs.2019.09.003 · Cited by 145 · cited 1×
“Moreover, it has been reported that obesity is concentrated among the rich in low-income countries and the poor in high-income countries [28].”
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angelidi, A. M., Belanger, M. J., Kokkinos, A. D., Koliaki, C. C., & Mantzoros, C. S. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab034 · Cited by 141 · cited 1×
“strategies we have recently reviewed extensively [58], other potential anti-obesity strategies are being explored, including novel drug delivery systems, vaccines, modulators of the gut microbiome, and gene therapy are currently under investigation.”
Self-citationAdiponectin: a link between obesity and cancer
Barb, D., Pazaitou‐Panayiotou, K., & Mantzoros, C. S. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.917 · Cited by 125 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Self-citationMediterranean diet as a nutritional approach for COVID-19
Angelidi, A. M., Kokkinos, A. D., Katechaki, E., Ros, E., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154407 · Cited by 112 · cited 1×
“lifestyle and the adoption of a balanced dietary practice, such as the Mediterranean diet, which is reputed for its demonstrated preventive effect of cardiovascular and metabolic disorders and obesity is of critical importance [48].”
Self-citationAdipose tissue and reproductive health
Mathew, H., Castracane, V. D., & Mantzoros, C. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.11.006 · Cited by 109 · cited 1×
“The fact that females constantly lead in terms of the proportions of obesity is expected, given the biologically driven higher percentage of body fat in women [25,26].”
Self-citationThe Socioeconomic Burden of Obesity
Kjellberg, J., Larsen, A. T., Ibsen, R., & Højgaard, B. (2017) · Obesity Facts · doi:10.1159/000480404 · Cited by 97 · cited 1×
“Similarly, BMI >30 kg/m2 has been linked with an increase in annual healthcare costs of approximately 37% [12].”
Vosoughi, K., Atieh, J., Khanna, L., Khoshbin, K., Prokop, L. J., Davitkov, P., Murad, M. H., & Camilleri, M. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101213 · Cited by 97
Obesity: seize the day, fight the fat
Pοlyzos, S. A., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.12.011 · Cited by 46 · cited 1×
“common causes for the obesity epidemic that is taking over many parts of the world during the last decades [15,16].”
Self-citationWoolcott, O. O., & Seuring, T. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071295 · Cited by 38
Editorial: Obesity, metabolic phenotypes and COVID-19
Sanoudou, D., Hill, M. A., Belanger, M. J., Arao, K., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155121 · Cited by 30
Self-citationMendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients
Qu, H., Qu, J., Glessner, J., & Hakonarson, H. H. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155156 · Cited by 20
Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity
Toumba, M., Fanis, P., Vlachakis, D., Neocleous, V., Phylactou, L. A., Skordis, N., Mantzoros, C. S., & Pantelidou, M. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5065 · Cited by 17 · cited 1×
“The purpose of this update is to reevaluate the global and regional prevalence and trends of overweight and obesity given the new advances in our knowledge on the pathophysiology of obesity and the resultant new therapeutic tools that have been introduced recently in the field [22,23].”
Self-citationPοlyzos, S. A., & Mantzoros, C. S. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2059974 · Cited by 13
Self-citationAn updated meta-analysis on the relationship between obesity and COVID-19 mortality
Wang, Y., Xu, J., Wang, Y., Hou, H., Feng, H., & Yang, H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154820 · Cited by 11
Sargent, M. G. (2009) · Nature · doi:10.1038/4581109a · Cited by 9 · cited 1×
“It is also of great interest that the economic disparity within a society may cause heterogeneity in obesity prevalence [31,32].”
Woolcott, O. O., & Seuring, T. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155027 · Cited by 8
Vityala, Y., Tagaev, T., Zhumabekova, A., & Маматов, С. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155011 · Cited by 8 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Morosanu, A., & Morosanu, M. (2022) · Metabolism · doi:10.1016/j.metabol.2021.155022 · Cited by 4 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Research works printed but not linked: 1
- Angelidi, 2021, Novel non-invasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy, Endocr Rev
Cited by
Sorted by citations
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Global epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00881-3 · Cited by 623
“Data from the USA and elsewhere indicate that age at menarche has been steadily decreasing and age at menopause increasing over the past 60 years 134 , while fertility rates have been decreasing 135 and obesity rates increasing 136 .”
Ahmed, S. K., & Mohammed, R. A. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100375 · Cited by 432
“Once associated primarily with affluent Western societies, obesity now burdens low-and middle-income countries at accelerating rates [8 – 10].”
Mediterranean diet in the management and prevention of obesity
Dominguez, L. J., Veronese, N., Bella, G. D., Cusumano, C., Parisi, A., Tagliaferri, F., Ciriminna, S., & Barbagallo, M. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112121 · Cited by 208
Obesity Paradox: Fact or Fiction?
Simati, S., Kokkinos, A. D., Dalamaga, Μ., & Argyrakopoulou, G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00497-1 · Cited by 186
Metadata
- Authors
- Boutari, C., & Mantzoros, C. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Mantzoros, Christos S.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 133
- Pages
- 155217
- ISSN
- 0026-0495 (ISSN-L)
- PMC
- PMC9107388
- OpenAlex
- W4280507423
- Cited by
- 1,068
- References
- 53
- Citations by year
- 2026: 176 · 2025: 331 · 2024: 344 · 2023: 188 · 2022: 27
- FWCI
- 196.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, overweight, obesity prevalence, obesity epidemiology, obesity epidemic, COVID-19 pandemic, sex differences in obesity, age-standardized prevalence, Global Burden of Disease Study, sedentary lifestyle, unhealthy diet, obesity-related comorbidities, diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular disease, obesity prevention policy
- MeSH terms
- COVID-19, Aged, Female, Humans, Male, Middle Aged, Obesity, Body Mass Index, Prevalence, Overweight, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
